Minoxidil Response Testing in Males With Androgenetic Alopecia
Launched by APPLIED BIOLOGY, INC. · Jul 22, 2014
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Males in overall good health
- • Age: 18 to 49
- • Diagnosed with male androgenetic alopecia with vertex pattern IIIv, IV, or V on the Norwood Hamilton Scale
- • Willing to have a mini dot tattoo placed in the target area of the scalp
- • Willing to maintain the same hair style, color, shampoo and hair products use, and approximate hair length throughout the study
- • Able to give informed consent
- • Able to comply with the study requirements for 16 consecutive weeks
- Exclusion Criteria:
- • Previous adverse event from topical minoxidil treatment
- • Does not use and have not used in the past 6 months anti-androgen therapy such as finasteride
- • Does not use and have not used in the past 6 months minoxidil (topical or oral)
- • Does not take medication known to cause hair thinning such as Coumadin and anti-depressants/anti-psychotics
- • Folliculitis
- • Scalp psoriasis
- • Seborrheic dermatitis
- • Inflammatory scalp conditions such as lichen planopilaris
About Applied Biology, Inc.
Applied Biology, Inc. is a pioneering biotechnology company focused on advancing innovative therapeutic solutions through the application of cutting-edge biological research and development. With a commitment to improving patient outcomes, the company specializes in the discovery and commercialization of novel treatments for a range of medical conditions, leveraging its expertise in molecular biology and biotechnology. Applied Biology, Inc. collaborates with leading academic institutions and industry partners to drive clinical trials that explore the efficacy and safety of its proprietary products, ultimately aiming to transform healthcare and enhance the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Tucson, Arizona, United States
East Melbourne, , Australia
Mumbai, , India
Florence, , Italy
Patients applied
Trial Officials
Sharon Keene, MD
Principal Investigator
Physicians Hair Institute
Flavio Grasso, MD
Principal Investigator
Istituto Medico Tricologico/Studi Life Cronos
Rodney Sinclair, MD
Principal Investigator
Sinclair Dermatology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials